Cisplatin-based chemotherapy for the treatment of metastatic collecting duct carcinomas: A real-world, retrospective analysis

Collecting duct carcinomas (CDCs) are a particularly rare subtype of kidney cancer, endowed by a particularly poor prognosis. Since no active treatments have been established for CDCs, due to similarities with upper tract urothelial carcinomas, the use of the cisplatin-gemcitabine doublet is usually...

Descripción completa

Detalles Bibliográficos
Autores principales: Rizzo, Mimma, Chiellino, Silvia, Gernone, Angela, Porta, Camillo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9624261/
https://www.ncbi.nlm.nih.gov/pubmed/36330500
http://dx.doi.org/10.3389/fonc.2022.939953

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9624261/
https://www.ncbi.nlm.nih.gov/pubmed/36330500
http://dx.doi.org/10.3389/fonc.2022.939953

Ejemplares similares